COLOSENSE
LIVE

Serial Number

97978982

Owner

GENEOSCOPY, INC.

Attorney

Matthew J. Smith

First Use Date

Sep 1, 2023

Filing Date

Nov 11, 2021

Add to watchlist:

No watchlists yet
View on USPTO

COLOSENSE Trademark

Serial Number: 97978982 • Registration: 7553527

COLOSENSE is a trademark filed by GENEOSCOPY, INC. on November 11, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GENEOSCOPY, INC. (9 trademarks)

2220 WELSCH INDUSTRIAL COURT
ST. LOUIS, MO 63146

Entity Type: 03

Geneoscopy, LLC (6 trademarks)

9300 Clayton Road
Saint Louis, MO 63124

Entity Type: 16

Trademark Details

Filing Date

November 11, 2021

Registration Date

October 29, 2024

First Use Anywhere

September 1, 2023

First Use in Commerce

September 1, 2023

Published for Opposition

October 25, 2022

Goods & Services

Diagnostic biomarkers for medical purposes for detecting cancer; Diagnostic preparations for medical purposes; biological preparations for the treatment of cancer

Medical screening services in the field of cancer; Medical analysis for the diagnosis and treatment of cancer; medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes in the field of cancer; Health care services, namely, for treating cancer; medical diagnosis and treatment of cancer; medical diagnosis of cancer; medical evaluation of cancer; medical services in the field of cancer; medical diagnostic services in the field of testing for cancer markers, including in a patient's excrement such as stool samples; providing a website featuring information in the field of the diagnosis and treatment of cancer; providing cancer screening services; providing information in the field of cancer prevention, screening, diagnosis and treatment; providing an on-line computer database in the field of cancer information for treatment and diagnostic purposes; providing information relating to diagnostics in the nature of medical diagnostic testing, monitoring and reporting information

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 29, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 29, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 25, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 25, 2024 CNPR
DIVISIONAL PROCESSING COMPLETE
Sep 24, 2024 DPCC
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2024 TROA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 16, 2024 AITU
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 18, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 18, 2024 XELR
DIVISIONAL REQUEST RECEIVED
May 14, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
May 14, 2024 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 19, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 19, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 20, 2024 DOCK
POST PUBLICATION AMENDMENT - ENTERED
Feb 12, 2024 CHPB
STATEMENT OF USE PROCESSING COMPLETE
Jan 8, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 6, 2024 AITU
USE AMENDMENT FILED
Dec 18, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 18, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 22, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 20, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 20, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 20, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2022 NOAM
ASSIGNED TO PETITION STAFF
Dec 7, 2022 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 16, 2022 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 29, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2021 NWOS
NEW APPLICATION ENTERED
Nov 15, 2021 NWAP